{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:29:18Z","timestamp":1648776558750},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.psym.2011.02.004","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T20:36:12Z","timestamp":1325622972000},"page":"92-95","source":"Crossref","is-referenced-by-count":0,"title":["First Report of Quetiapine Use in the Management of Ketamine-Benzodiazepine Coma Therapy Side-Effects"],"prefix":"10.1016","volume":"53","author":[{"given":"Angelica","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psym.2011.02.004_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.08.015","article-title":"Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study","volume":"147","author":"Schwartzman","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.psym.2011.02.004_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/14737175.6.5.669","article-title":"Pathophysiology of complex regional pain syndrome-development of new treatments","volume":"6","author":"Schwarzman","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.psym.2011.02.004_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3959(98)00154-7","article-title":"Windup leads to characteristics of central sensitization","volume":"79","author":"Li","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.psym.2011.02.004_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1533-2500.2007.00123.x","article-title":"Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam","volume":"7","author":"Kiefer","year":"2007","journal-title":"Pain Pract"},{"key":"10.1016\/j.psym.2011.02.004_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","article-title":"The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states","volume":"44","author":"Woolf","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.psym.2011.02.004_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1526-4637.2004.04043.x","article-title":"Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome","volume":"5","author":"Correll","year":"2004","journal-title":"Pain Med"},{"key":"10.1016\/j.psym.2011.02.004_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome Type 1","volume":"145","author":"Sigtermans","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.psym.2011.02.004_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psym.2011.02.004_bib9","first-page":"339","article-title":"Ketamine treatment for intractable pain in a patient with severe refractory complex regional pain syndrome: a case report","volume":"11","author":"Shirani","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.psym.2011.02.004_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130050741","article-title":"Seroquel, clozapine, and chlorpromazine restore sensorimotor gating in ketamine-treated rats","volume":"140","author":"Swerdlow","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psym.2011.02.004_bib11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1124\/jpet.103.052597","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment","volume":"306","author":"Tarazi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.psym.2011.02.004_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psym.2011.02.004_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-005-0092-6","article-title":"Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man","volume":"182","author":"Aalto","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psym.2011.02.004_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psym.2011.02.004_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainresrev.2008.07.006","article-title":"The acute effects of NMDA antagonism: from the rodent to the human brain","volume":"60","author":"Gunduz-Bruce","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.psym.2011.02.004_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharmacology"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318211001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318211001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T09:20:15Z","timestamp":1543310415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318211001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0033318211001290"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2011.02.004","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}